SCHEMBL6577652

SCHEMBL6577652

COC(=O)c1cccc(CCC(O)(c2ccccc2)N(C(C)C)C(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.52
CYP4A11 Q02928 2/20 0.52
SLC7A5 Q01650 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.47
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
HIF1A Q16665 1/20 0.43
FOLH1 Q04609 1/20 0.42
CETP P11597 1/20 0.42
NR3C1 P04150 1/20 0.41
MRGPRX4 Q96LA9 3/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PARP1 P09874 1/20 0.41
SENP1 Q9P0U3 1/20 0.41
IDO1 P14902 1/20 0.41
TSHR P16473 1/20 0.40
CASR P41180 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576164 0.88 GRM2 (0.43) HIF1AFOLH1MRGPRX4IDO1
SCHEMBL6577612 0.84 CYP4F2 (0.53) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL1926802 0.76 CYP4F2 (0.76) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL70173 0.74 CYP4F2 (0.83) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL6577714 0.72 GRM2 (0.41) HIF1AFOLH1MRGPRX4IDO1
SCHEMBL6574143 0.72 CHRM2 (0.46) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL1925403 0.72 CYP4F2 (0.69) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL6011697 0.72 CYP4F2 (0.73) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL6160155 0.70 CYP4F2 (0.71) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1
SCHEMBL14231980 0.70 CYP4F2 (0.58) CYP4F2CYP4A11SLC7A5LOXL2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383730-A2 ANTICHOLINERGIC COMPOUNDS AND METHODS OF USE Aryx Therapeutics (US) 2004-01-28 EP disclosed
WO-2002096855-A2 ANTICHOLINERGIC COMPOUNDS AND METHODS OF USE ARYX THERAPEUTICS (US) 2002-12-05 WO disclosed